BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1471917)

  • 1. The relation between the results of cytophotometric examination of endometrial carcinoma and clinical course of these disease.
    Köhler U; Taubert G; Bilek K; Nenning A
    Arch Gynecol Obstet; 1992; 252(2):93-7. PubMed ID: 1471917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytophotometric studies for evaluating the prognosis in endometrial cancer].
    Köhler U; Krug H; Taubert G
    Zentralbl Gynakol; 1991; 113(24):1371-9. PubMed ID: 1808964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Examination by image analysis for determining quantitative DNA parameters of serous papillary adenocarcinoma of the endometrium--a single case analysis].
    Köhler U; Horn LG; Naumann G; Nenning H; Bilek K
    Zentralbl Gynakol; 1995; 117(4):213-6. PubMed ID: 7778358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morphologic studies of endometrial cancer for biological assessment of nuclear grading].
    Köhler U
    Zentralbl Gynakol; 1991; 113(18):995-1003. PubMed ID: 1750299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simultaneous occurrence of a squamous epithelial and adenocarcinoma of the endometrium].
    Schumacher A; Haug A; Rohde E
    Zentralbl Gynakol; 1993; 115(6):279-81. PubMed ID: 8342351
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
    Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
    Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II.
    Wagenius G; Bergström R; Strang P; Gerdes U; Rogo K; Tribukait B; Stendahl U
    Anticancer Res; 1992; 12(3):725-32. PubMed ID: 1622130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low risk stage I endometrial carcinoma: prognostic factors and outcomes.
    Yoney A; Yildirim C; Bati Y; Unsal M
    Indian J Cancer; 2011; 48(2):204-10. PubMed ID: 21768667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative radiation therapy in clinical stage II endometrial carcinoma.
    Reisinger SA; Staros EB; Feld R; Mohiuddin M; Lewis GC
    Gynecol Oncol; 1992 May; 45(2):174-8. PubMed ID: 1317330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual myometrial invasion after intracavitary irradiation of endometrial adenocarcinoma stages I and II. Relations to DNA content and S-phase rate.
    Wagenius G; Strang P; Boman K; Tribukait B; Stendahl U
    In Vivo; 1988; 2(3-4):243-5. PubMed ID: 2979839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
    Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of endometrial carcinoma.
    Irwin CJ
    Br J Hosp Med; 1996 Mar 20-Apr 2; 55(6):308-10. PubMed ID: 8696621
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathologic study of endometrial carcinoma with special reference to new histological variants.
    Sato Y; Ozaki M; Ueda G; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):1015-9. PubMed ID: 2991395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five year survival rate in endometrial carcinoma stages I--II: influence of degree of tumour differentiation, age, myometrial invasion and DNA content.
    Lindahl B; Ranstam J; Willén R
    Br J Obstet Gynaecol; 1994 Jul; 101(7):621-5. PubMed ID: 8043542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic versus open surgery for endometrial cancer: a minimum 3-year follow-up study.
    Ghezzi F; Cromi A; Uccella S; Siesto G; Giudici S; Serati M; Franchi M
    Ann Surg Oncol; 2010 Jan; 17(1):271-8. PubMed ID: 19826876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study.
    Coronado PJ; Fasero M; Baquedano L; Martinez-Maestre MA; Casado A; Vidart JA; Herraiz MA
    Int J Gynecol Cancer; 2014 May; 24(4):703-12. PubMed ID: 24651627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial.
    Eltabbakh GH; Piver MS; Hempling RE; Shin KH
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):373-80. PubMed ID: 9226326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.